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Chelation therapy is a consolidated medical procedure used primarily to hinder the 
effects of toxic metal ions on human tissues [1]. Its application spans a broad spectrum of 
disorders, ranging from acute metal intoxication to genetic metal-overload. The use of 
chelating agents is compromised by a number of serious side effects, mainly attributable to 
perturbed equilibrium of essential metal ion homeostasis and dislocation of complexed metal 
ions to dangerous body sites. For this reason, chelation therapy has been limited to specific 
critical and otherwise untreatable conditions and needs to be monitored within an appropriate 
clinical context [2-3]. An alarming issue today is that fraudsters use the term “chelation 
therapy” to take advantage of and make profit from people with tragic health problems. We 
believe that scientists working in this field have the corollary obligation to deter these frauds 
and to inform the scientific community of the possible side effects and complications of 
chelation therapy. This duty is all the more important if we consider the detrimental and even 
life threatening consequences that can occur in subjects with no clear clinical and laboratory 
evidence of metal intoxication. The aim of this communication is to present how this “false 
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